Navigation

Male lower urinary tract symptoms (LUTS)

The management of male lower urinary tract symptoms (LUTS)

Status: History
Publication date: May 2010
Wave: 14
Process: CG
Topic area:
  • Urogenital
 

NICE project team

Centre for clinical practice lead: Phil Alderson
Communications manager: Paul Cooney
Guidelines commissioning manager: Sarah Willett
Guidelines coordinator: Andrew Gyton
Patient involvement lead: Barbara Meredith
Implementation lead: Katie Worrall
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Scoping workshop: 06 September 2007
Consultation on draft scope with stakeholders: 4 September - 1 October 2007
Consultation on draft guideline with stakeholders: 28 August - 23 October 2009
Pre-publication check: 29 January 2010
Publication date: May 2010
Top


 

Project history

Date Update  
18 July 2007 The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to whom it will apply.  
4 September 2007 The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown.  
28 September 2007 Please note that the guideline relating to men with lower urinary tract symptoms will be combined with the 14th wave guideline relating to benign prostatic hyperplasia, to provide guidance covering the management of lower urinary tract symptoms and the management of associated benign prostatic hyperplasia. We have extended the consultation period on this guideline to allow organisations who have not yet registered as a stakeholders the opportunity to do so. The consultation will now close on the 29 October.  
30 October 2007 Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply.  
18 January 2008 The scope defines what aspects of care are covered by the guideline and to whom it applies.

Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.

The Guideline Development Group (GDG) oversees the development process. See below for a list of GDG members.

The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary.

In addition, the NCCs will accept relevant confidential data for consideration by the GDG.

Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline. Please see timescales above for dates of consultation with stakeholders.
 
1 April 2009 Responsibility for the development of this guideline has transferred to the National Clinical Guidelines Centre for Acute and Chronic Conditions. Key contacts and timelines remain unchanged.  
28 August 2009 The consultation draft of the guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.  
29 January 2010 The final draft of the full guideline is available for its pre-publication check. If you wish to report a factual error you need to do so via one of the registered stakeholder organisations listed, by the deadline shown  
7 April 2010 The NHS, like all public bodies, is expected to be politically impartial; so as to avoid providing a focus for political debate or detract attention from the general election campaign, NICE will not publish any guidance document, either in draft or final form, until the election has concluded. Therefore this clinical guideline, along with other final NICE guidance due for publication in April, will now be published in May 2010.  
Top


 

Key documents

This page was last updated: 22 December 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.